Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2011, Article ID 482973, 9 pages
http://dx.doi.org/10.1155/2011/482973
Review Article

A Review of the Receptor-Binding Properties of p-Synephrine as Related to Its Pharmacological Effects

1School of Pharmacy and Health Professions, Creighton University Medical Center, Omaha, NE 68178, USA
2Department of Medicine and Pathology, Georgetown University Medical Center, Washington, DC 22039, USA
3Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan

Received 18 January 2011; Accepted 7 June 2011

Academic Editor: Neelam Khaper

Copyright © 2011 Sidney J. Stohs et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Pellati, S. Benvenuti, and M. Melegari, “High-pressure liquid chromatography methods for the analysis of adrenergic amines and flavanones in Citrus aurantium L. var. amara,” Phytochemical Analysis, vol. 15, no. 4, pp. 220–225, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. F. Pellati, S. Benvenuti, M. Melegari, and F. Firenzuoli, “Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 6, pp. 1113–1119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Pellati, S. Benvenuti, and M. Melegari, “Enantioselective LC analysis of synephrine in natural products on a protein-based chiral stationary phase,” Journal of Pharmaceutical and Biomedical Analysis, vol. 37, no. 5, pp. 839–849, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. B. Avula, S. K. Upparapalli, A. Navarrete, and I. A. Khan, “Simultaneous quantification of adrenergic amines and flavonoids in C. aurantium, various Citrus species, and dietary supplements by liquid chromatography,” Journal of Association of Official Analytical Chemists International, vol. 88, no. 6, pp. 1593–1606, 2005. View at Google Scholar · View at Scopus
  5. M. D. Arbo, E. R. Larentis, V. M. Linck et al., “Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine,” Food and Chemical Toxicology, vol. 46, no. 8, pp. 2770–2775, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. L. Mattoli, F. Cangi, A. Maidecchi, C. Ghiara, M. Stubaro, and P. A. Tralda, “A rapid liquid electrospray ionization mass spectroscopy method for evaluation aurantium L samples,” Journal of Agricultural and Food Chemistry, vol. 53, pp. 9860–9866, 2005. View at Google Scholar
  7. T. Tsujita and T. Takaku, “Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark),” Journal of Nutritional Science and Vitaminology, vol. 53, no. 6, pp. 547–551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Mercolini, R. Mandrioli, T. Trerè, F. Bugamelli, A. Ferranti, and M. A. Raggi, “Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements,” Journal of Separation Science, vol. 33, no. 16, pp. 2520–2527, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. C. Roman, J. M. Betz, and J. Hildreth, “Determination of synephrine in bitter orange raw materials, extracts, and dietary supplements by liquid chromatography with ultraviolet detection: single laboratory validation,” Association of Official Analytical Chemists Journal, vol. 90, no. 1, pp. 68–81, 2007. View at Google Scholar · View at Scopus
  10. L. G. Rossato, P. G. de Pinho, R. Silva et al., “Development and validation of a GC/IT-MS method for simultaneous quantification of the para and meta-synephrine in biological samples,” Journal of Pharmaceutical and Biomedical Analysis, vol. 52, pp. 721–726, 2010. View at Google Scholar
  11. D. W. Percy, J. L. Adcock, X. A. Conlan et al., “Determination of Citrus aurantium protoalkaloids using HPLC with acidic potassium permanganate chemiluminescence detection,” Talanta, vol. 80, no. 5, pp. 2191–2195, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. B. C. Nelson, K. Putzbach, K. E. Sharpless, and L. C. Sander, “Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium),” Journal of Agricultural and Food Chemistry, vol. 55, no. 24, pp. 9769–9775, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. L. C. Sander, K. Putzbach, B. C. Nelson et al., “Certification of standard reference materials containing bitter orange,” Analytical and Bioanalytical Chemistry, vol. 391, no. 6, pp. 2023–2034, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. Dragull, A. P. Breksa, and B. Cain, “Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch),” Journal of Agricultural and Food Chemistry, vol. 56, no. 19, pp. 8874–8878, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. R. M. Uckoo, G. K. Jayaprakasha, S. D. Nelson, and B. S. Patil, “Rapid simultaneous determination of amines and organic acids in citrus using high-performance liquid chromatography,” Talanta, vol. 83, no. 3, pp. 948–954, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. McGuffin, “Media spins numbers on bitter orange AERs based on erroneous infor-mation from FDA,” HerbalGram, vol. 2006, pp. 52–55, 2006. View at Google Scholar
  17. S. J. Stohs, “A review and assessment of the FDA adverse events reports and clinical case reports between April 2004 and October 2009,” Journal of Functional Foods, vol. 2, pp. 235–238, 2010. View at Google Scholar
  18. S. J. Stohs and H. G. Preuss, “The safety of bitter orange (Citrus aurantium) and p-synephrine,” HerbalGram, vol. 89, pp. 34–39, 2011. View at Google Scholar
  19. S. Bent, A. Padula, and J. Neuhaus, “Safety and efficacy of citrus aurantium for weight loss,” American Journal of Cardiology, vol. 94, no. 10, pp. 1359–1361, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. S. R. Penzak, M. W. Jann, J. A. Cold, Y. Y. Hori, H. D. Desai, and B. J. Gurley, “Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults,” Journal of Clinical Pharmacology, vol. 41, no. 10, pp. 1059–1063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Fugh-Berman and A. Myers, “Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research,” Experimental Biology and Medicine, vol. 229, no. 8, pp. 698–704, 2004. View at Google Scholar · View at Scopus
  22. S. Haaz, K. Y. Williams, K. R. Fontaine, and D. R. Allison, “Bitter orange,” in Encyclopedia of Dietary Supplements, P. M. Coates, M. R. Blackman, G. M. Cragg, M. Levine, J. Moss, and J. D. White, Eds., pp. 52–59, Marcel Dekker, New York, NY, USA, 2nd edition, 2010. View at Google Scholar
  23. L. G. Rossato, V. M. Costa, R. P. Limberger, M. D. L. Bastos, and F. Remião, “Synephrine: from trace concentration to massive consumption in weight-loss,” Food and Chemical Toxicology, vol. 49, no. 1, pp. 8–16, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. A. Inchiosa Jr., “Evidence (mostly negative) with the use of sympathomimetic agents for weight loss,” Journal of Obesity, vol. 2011, Article ID 764584, 4 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  25. Anon, “CFSAN examines AER reporting following bitter orange miscalculation,” The Tan Sheet, vol. 12, pp. 11–12, 2004. View at Google Scholar
  26. F. Pellati and S. Benvenuti, “Chromatographic and electrophoretic methods for the analysis of phenethylamine alkaloids in Citrus aruantium,” Journal of Chromatography A, vol. 1171, pp. 71–88, 2007. View at Google Scholar
  27. D. Jones, “Citrus and ephedra,” Whole Foods, pp. 40–41, 2004. View at Google Scholar
  28. R. Jordan, C. M. Thonoor, and C. M. Williams, “Beta-adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea,” Journal of Pharmacy and Pharmacology, vol. 39, pp. 752–754, 1987. View at Google Scholar
  29. G. Ma, S. A. Bavadekar, B. T. Schaneberg, I. A. Khan, and D. R. Feller, “Effects of synephrine and β-phenethylamine on human α-adrenoceptor subtypes,” Planta Medica, vol. 76, no. 10, pp. 981–986, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. C. M. Brown, J. C. McGrath, J. M. Midgley, A. G. Muir, J. W. O’Brien et al., “Activities of octapamine and synephrine stereoisomers on alpha-adrenoreceptors,” British Journal of Pharmacology, vol. 93, pp. 417–429, 1988. View at Google Scholar
  31. J. Hwa and D. M. Perez, “The unique nature of the serine interactions for α1-adrenergic receptor agonist binding and activation,” Journal of Biological Chemistry, vol. 271, no. 11, pp. 6322–6327, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Hibino, M. Yuzurihara, Y. Kase, and A. Takeda, “Synephrine, a component of Evodiae fructus, constricts isolated aorta via adrenergic and serotonergic receptors,” Journal of Pharmacological Sciences, vol. 111, no. 1, pp. 73–81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Haller, N. L. Benowitz, and P. Jacob III, “Hemodynamic effects of ephedra-free weight-loss supplements in humans,” American Journal of Medicine, vol. 118, no. 9, pp. 998–1003, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. L. G. Rossato, V. M. Costa, P. G. dePinho, F. Caryalho, B. M. deLourdes, and F. Remiao, “Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes,” Archives of Toxicology. In press. View at Publisher · View at Google Scholar · View at PubMed
  35. J. R. S. Arch, “β3-adrenoceptor agonists: potential, pitfalls and progress,” European Journal of Pharmacology, vol. 440, no. 2-3, pp. 99–107, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Alemzadeh, M. D. Karlstad, K. Tushaus, and M. Buchholz, “Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats,” Metabolism, vol. 57, no. 11, pp. 1597–1607, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. F. Oana, T. Homma, H. Takeda et al., “DNA microarray analysis of white adipose tissue from obese (fa/fa) Zucker rats treated with a β3-adrenoceptor agonist, KTO-7924,” Pharmacological Research, vol. 52, no. 5, pp. 395–400, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. B. S. Hamilton and H. N. Doods, “Identification of potent agonists acting at an endogenous atypical β3-adrenoceptor state that modulate lipolysis in rodent fat cells,” European Journal of Pharmacology, vol. 580, no. 1-2, pp. 55–62, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. N. K. Canova, D. Lincova, E. Kmonickova, and H. Farghili, “Nitric oxide production from rat adipocytes in modulated by β-3 adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes,” Nitric Oxide, vol. 14, pp. 200–211, 2006. View at Google Scholar
  40. A. G. Dulloo, “Ephedrine, xanthines and prostaglandin inhibitors: actions and interactions in the stimulation of thermogenesis,” International Journal of Obesity, vol. 17, no. 1, pp. 1040–1049, 1993. View at Google Scholar · View at Scopus
  41. C. Carpene, J. Galitzky, E. Fontana, C. Algie, M. Lafontan, and E. Berlan, “Selective activation of beta 3-adrenoreceptors by octopamine: comparative studies in mammalian fat cells,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 359, pp. 310–321, 1999. View at Google Scholar
  42. T. Tsujita and T. Takaku, “Lipolysis induced by segment wall extract from Satsuma mandarin orange (Citrus unshu Mark),” Journal of Nutritional Science and Vitaminology, vol. 53, no. 6, pp. 547–551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. H. S. Parmar and A. Kar, “Medicinal values of fruit peels from Citrus sisensis, Punica granatum, and Musa paradisiacal with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones,” Journal of Medicinal Food, vol. 11, no. 2, pp. 376–381, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. H. S. Parmar and A. Kar, “Antiperoxidative, antithyroidal, antihyperglycemic and cardioprotective role of Citrus sinensis peel extract in male mice,” Phytotherapy Research, vol. 22, no. 6, pp. 791–795, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. J. R. Shannon, K. Gottesdiener, J. Jordan et al., “Acute effect of epinephrine on 24-h energy balance,” Clinical Science, vol. 96, no. 5, pp. 483–491, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. M. D. Arbo, G. C. Schmitt, M. F. Limberger et al., “Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice,” Regulatory Toxicology and Pharmacology, vol. 54, pp. 114–117, 2009. View at Google Scholar
  47. K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270–278, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. J. Bouayed and T. Bohn, “Exogenous antioxidants—double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 4, pp. 228–237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. D. K. Hansen, B. E. Julier, G. E. White, and L. S. Pellicore, “Developmental toxicity of Citrus aurantium in rats,” Birth Defects Research, vol. 92, no. 3, pp. 216–223, 2011. View at Publisher · View at Google Scholar · View at PubMed
  50. J. Mercader, E. Wanecq, J. Chen, and C. Carpene, “Isonorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium,” Journal of Physiology and Biochemistry. In press. View at Publisher · View at Google Scholar · View at PubMed
  51. B. Rozec and C. Gauther, “β3-Adrenoreceptors in the cardiovascular system: putative roles in human pathologies,” Pharmacology & Therapeutics, vol. 111, pp. 652–673, 2006. View at Google Scholar
  52. A. L. Moens, R. Yang, V. L. Watts, and L. A. Barouch, “Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 6, pp. 1088–1095, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. N. P. Riksen, P. Smits, and G. A. Rongen, “The cardiovascular effects of methylxanthines,” Handbook of Experimental Pharmacology, vol. 200, pp. 413–437, 2011. View at Google Scholar
  54. A. Yang, A. A. Palmer, and H. DeWit, “Genetics of caffeine consumption and responses to coffee,” Psychopharmacology, vol. 211, pp. 245–257, 2010. View at Google Scholar
  55. U. Lind, R. M. Alm, F. L. Hasselberg et al., “Octopamine receptors from the barnacle Balanus improvisus are activated by the α2-adrenoceptor agonist medetomidine,” Molecular Pharmacology, vol. 78, no. 2, pp. 237–248, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. T. Farooqui, “Octopamine-mediated neuromodulation of insect senses,” Neurochemical Research, vol. 32, no. 9, pp. 1511–1529, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. P. D. Evans and B. Maqueira, “Insect octopamine receptors: a new classification scheme based on studies of cloned Drosophila G-protein coupled receptors,” Invertebrate Neuroscience, vol. 5, no. 3-4, pp. 111–118, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. V. Blais, N. Bounif, and F. Dubé, “Characterization of a novel octopamine receptor expressed in the surf clam Spisula solidissima,” General and Comparative Endocrinology, vol. 167, no. 2, pp. 215–227, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. J. Rillich, K. Schildberger, and P. A. Stevenson, “Octopamine and occupancy: an aminergic mechanism for intruder-resident aggression in crickets,” Proceedings. Biological sciences, vol. 278, pp. 1873–1880, 2010. View at Google Scholar
  60. P. D. Evans, C. M. Thonoor, and J. M. Midgley, “Activities of octopamine and synephrine stereoisomers on octopaminergic receptor subtypes in locust skeletal muscle,” Journal of Pharmacy and Pharmacology, vol. 40, no. 12, pp. 855–861, 1988. View at Google Scholar · View at Scopus
  61. J. H. Park and L. L. Keeley, “The effect of biogenic amines and their analogs on carbohydrate metabolism in the fat body of the cockroach Blaberus discoidalis,” General and Comparative Endocrinology, vol. 110, no. 1, pp. 88–95, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. L. W. Klaassen and A. E. Kammer, “Octopamine enhances neuromuscular transmission in developing and adult moths, Manduca sexta,” Journal of Neurobiology, vol. 16, no. 3, pp. 227–243, 1985. View at Google Scholar · View at Scopus
  63. C. M. Colker, D. S. Kalman, G. C. Torina, T Perlis, and C. Street, “Effects of Citrus aurantium extract, caffeine and St. John’s wort on body fat loss, lipid levels and mood states in normal weight and obese individuals,” Current Therapeutic Research, vol. 60, no. 3, pp. 145–153, 1999. View at Google Scholar
  64. B. Min, D. Cios, J. Kluger, and C. M. White, “Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter orange extract in healthy subjects,” Pharmacotherapy, vol. 25, no. 12, pp. 1719–1724, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. C. Sale, R. C. Harris, S. Delves, and J. Corbett, “Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males,” International Journal of Obesity, vol. 30, no. 5, pp. 764–773, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. R. Gougeon, K. Harrigan, J. F. Tremblay, P. Hedrei, M. Lamarche, and J. A. Morais, “Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium,” Obesity Research, vol. 13, no. 7, pp. 1187–1194, 2005. View at Google Scholar · View at Scopus
  67. J. L. Zenk, S. A. Leikam, L. J. Kassen, and M. A. Kuskowski, “Effect of lean system 7 on metabolic rate and body composition,” Nutrition, vol. 21, no. 2, pp. 179–185, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. J. R. Hoffman, J. Kang, A. Ratamess, P. F. Jennings, G. Mangione, and A. D. Faigenbaum, “Thermogenic effect from nutritionally enriched coffee consumption,” Journal of the International Society of Sports Nutrition, vol. 3, pp. 35–43, 2006. View at Google Scholar
  69. S. J. Stohs, H. G. Preuss, S. C. Keith, P. L. Keith, H. Miller, and G. R. Kaats, “Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabol-ism, blood pressure, heart rate and self-reported mood changes,” International Journal of Medical Sciences, vol. 8, pp. 295–301, 2011. View at Google Scholar
  70. J. G. Seifert, A. Nelson, J. Devonish, E. R. Burke, and S. J. Stohs, “Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans,” International Journal of Medical Sciences, vol. 8, pp. 192–197, 2001. View at Google Scholar
  71. C. A. Haller, M. Duan, J. Peyton III, and N. Benowitz, “Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions,” British Journal of Clinical Pharmacology, vol. 65, no. 6, pp. 833–840, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. J. P. Smedema and G. J. Müller, “Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine,” South African Medical Journal, vol. 98, no. 5, pp. 372–373, 2008. View at Google Scholar · View at Scopus
  73. T. A. Stephensen and R. Sarlay, “Ventricular fibrillation associated with use of synephrine containing dietary supplement,” Military Medicine, vol. 174, no. 12, pp. 1313–1319, 2009. View at Google Scholar · View at Scopus
  74. K. Clauson, K. M. Shields, C. E. McQuee, and N. Persad, “Safety issues associated with commercially available energy drinks,” Journal of the American Pharmacists Association, vol. 48, pp. e55–e65, 2008. View at Google Scholar
  75. G. Calapai, F. Firenzuoli, A. Saitta et al., “Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report,” Fitoterapia, vol. 70, no. 6, pp. 586–592, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. L. Titta, M. Trinei, M. Stendardo et al., “Blood orange juice inhibits fat accumulation in mice,” International Journal of Obesity, vol. 34, no. 3, pp. 578–588, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. Y. T. Huang, H. C. Lin, Y. Y. Chang, Y. Y. Yang, S. D. Lee, and C. Y. Hong, “Hemodynamic effects of synephrine treatment in portal hypertensive rats,” Japanese Journal of Pharmacology, vol. 85, no. 2, pp. 183–188, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. L. T. Bui, D. T. Nguyen, and P. J. Ambrose, “Blood pressure and heart rate effects following a single dose of bitter orange,” Annals of Pharmacotherapy, vol. 40, no. 1, pp. 53–57, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. J. H. Hengstmann and H. Aulepp, “Pharmacokinetics and metabolism of 3H-synephrine,” Arzneimittel-Forschung/Drug Research, vol. 28, no. 12, pp. 2326–2331, 1978. View at Google Scholar · View at Scopus
  80. J. Oben, E. Enonchong, S. Kothari, W. Chambliss, R. Garrison, and D. Dolnick, “Phellodendron and Citrus extracts benefit cardiovascular health in osteoarthritis patients: a double-blind, placebo-controlled pilot study,” Nutrition Journal, vol. 7, no. 1, pp. 16–21, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. S. J. Stohs and M. Shara, “A review of the safety and efficacy of Citrus aurantium in weight management,” in Obesity: Epidemiology, Pathophysiology, and Prevention, D. Bagchi and H. G. Preuss, Eds., pp. 371–382, CRC Press, Boca Raton, Fla, USA, 2007. View at Google Scholar
  82. S. J. Stohs and M. Shara, “A review of the safety and efficacy of bitter orange (Citrus aurantium) and its primary protoalkaloid p-synephrine in weight management,” in Obesity: Epidemiology, Pathophysiology and Prevention, D. Bagchi and H. G. Preuss, Eds., CRC Press, Boca Raton, Fla, USA, 2nd edition, 2011. View at Google Scholar